Trial Profile
A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction of LY2216684 With Alcohol in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Alcohol
- Indications Attention-deficit hyperactivity disorder; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 19 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 08 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.